NASDAQ:HCWB

Hcw Biologics Stock Insider Trading

Healthcare > Biotechnology

Buy HCWB

*Your capital is at risk

$3.20

+0.0500 (+1.59%)

At Close: Jul 31, 2026

HCW Biologics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 5.06M and sold 0 HCWB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	5.06M shares
● Sell	0 shares
100% Buy Activity Strong Negative Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Sep 14, 2023 Buy	Common Stock P-Purchase	Winer Gary M Director	Director	879 Value: $2K
Sep 14, 2023 Buy	Common Stock P-Purchase	Winer Gary M Director	Director	162 Value: $337
Sep 14, 2023 Buy	Common Stock P-Purchase	Winer Gary M Director	Director	879 Value: $2K
Sep 13, 2023 Buy	Common Stock P-Purchase	Byam Rebecca Chief Financial Officer	C-Suite Officer	5 000 Value: $10.5K
Sep 13, 2023 Buy	Common Stock P-Purchase	Winer Gary M Director	Director	46 Value: $92
Sep 13, 2023 Buy	Common Stock P-Purchase	Winer Gary M Director	Director	500 Value: $1K
Sep 13, 2023 Buy	Common Stock P-Purchase	Byam Rebecca Chief Financial Officer	C-Suite Officer	5 000 Value: $10.5K
Sep 13, 2023 Buy	Common Stock P-Purchase	Winer Gary M Director	Director	46 Value: $92
Sep 13, 2023 Buy	Common Stock P-Purchase	Winer Gary M Director	Director	500 Value: $1K
Sep 12, 2023 Buy	Common Stock P-Purchase	Byam Rebecca Chief Financial Officer	C-Suite Officer	5 000 Value: $10.4K
Sep 12, 2023 Buy	Common Stock P-Purchase	Byam Rebecca Chief Financial Officer	C-Suite Officer	5 000 Value: $10.4K
Sep 12, 2023 Buy	Common Stock P-Purchase	Winer Gary M Director	Director	500 Value: $1K
Sep 12, 2023 Buy	Common Stock P-Purchase	Winer Gary M Director	Director	500 Value: $1K
Sep 11, 2023 Buy	Common Stock P-Purchase	Byam Rebecca Chief Financial Officer	C-Suite Officer	5 000 Value: $10.3K
Sep 11, 2023 Buy	Common Stock P-Purchase	Byam Rebecca Chief Financial Officer	C-Suite Officer	5 000 Value: $10.3K
Sep 11, 2023 Buy	Common Stock P-Purchase	Winer Gary M Director	Director	99 Value: $203
Sep 11, 2023 Buy	Common Stock P-Purchase	Winer Gary M Director	Director	99 Value: $203
Sep 08, 2023 Buy	Common Stock P-Purchase	Winer Gary M Director	Director	1 Value: $2
Sep 08, 2023 Buy	Common Stock P-Purchase	Winer Gary M Director	Director	1 Value: $2
Sep 08, 2023 Buy	Common Stock P-Purchase	Byam Rebecca Chief Financial Officer	C-Suite Officer	5 000 Value: $10.1K
Sep 08, 2023 Buy	Common Stock P-Purchase	Byam Rebecca Chief Financial Officer	C-Suite Officer	5 000 Value: $10.1K
Sep 07, 2023 Buy	Common Stock P-Purchase	Byam Rebecca Chief Financial Officer	C-Suite Officer	5 000 Value: $10K
Sep 07, 2023 Buy	Common Stock P-Purchase	Byam Rebecca Chief Financial Officer	C-Suite Officer	5 000 Value: $10K
Sep 06, 2023 Buy	Common Stock P-Purchase	Byam Rebecca Chief Financial Officer	C-Suite Officer	5 000 Value: $10K
Sep 05, 2023 Buy	Common Stock P-Purchase	Winer Gary M Director	Director	400 Value: $700

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT HCW BIOLOGICS INC.

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata ...

Read Full Profile Here